Jackson S Musuuza1, Ajay K Sethi2, Tonya J Roberts3, Nasia Safdar4. 1. William S. Middleton Memorial Veterans Affairs Hospital, Madison, WI; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI. 2. Department of Population Health Sciences, University of Wisconsin, Madison, WI. 3. William S. Middleton Memorial Veterans Affairs Hospital, Madison, WI; School of Nursing, University of Wisconsin, Madison, WI. 4. William S. Middleton Memorial Veterans Affairs Hospital, Madison, WI; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI. Electronic address: ns2@medicine.wisc.edu.
Abstract
BACKGROUND: Colonized patients are a reservoir for transmission of multidrug-resistant organisms (MDROs). Not many studies have examined the effectiveness of daily chlorhexidine gluconate (CHG) bathing under routine care conditions. We present a descriptive analysis of the trends of MDRO colonization following implementation of daily CHG bathing under routine clinical conditions in an intensive care unit (ICU). METHODS: From May 2010-January 2011, we screened patients admitted to a 24-bed ICU for and methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and fluoroquinolone-resistant gram-negative bacilli (FQRGNB). We calculated and plotted monthly incidence and prevalence of colonization of these MDROs. RESULTS: Prevalence decreased in the immediate aftermath of daily CHG bathing implementation and generally remained at that level throughout the observation period. We observed low rates of incidence of MDRO colonization with VRE>FQRGNB>MRSA. Monthly prevalence of colonization and incidence for the composite of MRSA, VRE, and/or FQRGNB was 1.9%-27.9% and 0-1.1/100 patient-days, respectively. CONCLUSIONS: Following the implementation of daily CHG bathing, the incidence of MDROs remained low and constant over time, whereas the prevalence decreased immediately after the implementation. Published by Elsevier Inc.
BACKGROUND: Colonized patients are a reservoir for transmission of multidrug-resistant organisms (MDROs). Not many studies have examined the effectiveness of daily chlorhexidine gluconate (CHG) bathing under routine care conditions. We present a descriptive analysis of the trends of MDRO colonization following implementation of daily CHG bathing under routine clinical conditions in an intensive care unit (ICU). METHODS: From May 2010-January 2011, we screened patients admitted to a 24-bed ICU for and methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and fluoroquinolone-resistant gram-negative bacilli (FQRGNB). We calculated and plotted monthly incidence and prevalence of colonization of these MDROs. RESULTS: Prevalence decreased in the immediate aftermath of daily CHG bathing implementation and generally remained at that level throughout the observation period. We observed low rates of incidence of MDRO colonization with VRE>FQRGNB>MRSA. Monthly prevalence of colonization and incidence for the composite of MRSA, VRE, and/or FQRGNB was 1.9%-27.9% and 0-1.1/100 patient-days, respectively. CONCLUSIONS: Following the implementation of daily CHG bathing, the incidence of MDROs remained low and constant over time, whereas the prevalence decreased immediately after the implementation. Published by Elsevier Inc.
Entities:
Keywords:
Antiseptics; Bacterial colonization; Infection prevention; Sustainability of intervention
Authors: Rebecca R Roberts; R Douglas Scott; Bala Hota; Linda M Kampe; Fauzia Abbasi; Shari Schabowski; Ibrar Ahmad; Ginevra G Ciavarella; Ralph Cordell; Steven L Solomon; Reidar Hagtvedt; Robert A Weinstein Journal: Med Care Date: 2010-11 Impact factor: 2.983
Authors: John C O'Horo; Germana L M Silva; L Silvia Munoz-Price; Nasia Safdar Journal: Infect Control Hosp Epidemiol Date: 2012-01-25 Impact factor: 3.254
Authors: Michael W Climo; Deborah S Yokoe; David K Warren; Trish M Perl; Maureen Bolon; Loreen A Herwaldt; Robert A Weinstein; Kent A Sepkowitz; John A Jernigan; Kakotan Sanogo; Edward S Wong Journal: N Engl J Med Date: 2013-02-07 Impact factor: 91.245
Authors: Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin Journal: N Engl J Med Date: 2014-03-27 Impact factor: 91.245
Authors: Jin Woong Suh; Nam Hee Kim; Min Jung Lee; Seoung Eun Lee; Byung Chul Chun; Chang Kyu Lee; Juneyoung Lee; Jong Hun Kim; Sun Bean Kim; Young Kyung Yoon; Jang Wook Sohn; Min Ja Kim Journal: Antimicrob Resist Infect Control Date: 2021-11-10 Impact factor: 4.887